Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium

Immunotherapy, Ahead of Print.

Source: Immunotherapy - August 23, 2023 Category: Allergy & Immunology Authors: Elena Carmona-Rocha Llu ís Puig Source Type: research